CLINICAL_TRIALS trial_result · 2020-10-08

Clinical Trial Update: Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating EN3835 for cellulite (Edematous Fibrosclerotic Panniculopathy) in women has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Edematous Fibrosclerotic Panniculopathy (Cellulite) | Phase 3 | Status: COMPLETED | Results posted: 2020-10-08